Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)

NCT02635776 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
555
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aimmune Therapeutics, Inc.